High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0294698 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Wenkosi Qulu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa. Hauptthemen laut MEDLINE: Vaginosis, Bacterial, Papillomavirus Infections, Uterine Cervical Neoplasms, Sexually Transmitted Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Poliomyelitis Research Foundation, United States – South African Program for Collaborative Biomedical Research grant.
Abstract (Originalsprache)
Introduction
Human papillomavirus (HPV) infection is a leading cause of cervical cancer. Although this relies on infection and persistence of HPV in epithelial cells, often occurring in the context of other sexually transmitted infections (STIs) and bacterial vaginosis (BV), data on the relationships between these and their relative effects on epithelial barrier integrity in women remain sparse. This study describes the epidemiology of HPV combined with STI and/or BV prevalence and the relative impact on matrix metalloproteinases (MMPs) among South African women.
Methods
Roche Linear Array was used for HPV genotyping in menstrual cup pellets of 243 HIV-negative women participating in the CAPRISA 083 cohort study. Vulvovaginal swabs were tested for Chlamydia trachomatis , Neisseria gonorrhoeae , and Trichomonas vaginalis using Xpert® CT/NG assay and lateral flow assay, and Gram staining was performed to diagnose BV using Nugent scoring criteria. Concentrations of 5 MMPs were measured in menstrual cup supernatants by multiplexed ELISA. Fisher’s exact tests, Mann-Whitney U tests, and multivariable regression models determined associations between HPV infection, STI and/or BV, and MMP concentrations.
Results
HPV was prevalent in 34% of women (83/243; median 23 years, interquartile range (IQR) 21–27 years). Low-risk (lr) (71%, 59/83) and high-risk (hr)-HPV infections (54.2%, 45/83) were common. Hr-HPV was frequently detected in STI and/or BV-positive women compared to women without STIs or BV (p = 0.029). In multivariable analysis, BV was associated with increased odds of hr-HPV detection (OR: 2.64, 95%CI: 1.02–6.87, p = 0.046). Furthermore, Gardasil®9 vaccine-type strains were more frequently detected in women diagnosed with STI and/or BV (55.2%, 32/58 vs 24%, 6/25; p = 0.009). Among STI and/or BV-positive women, HPV detection was significantly associated with increased MMP-10 concentrations (b = 0.55, 95% CI 0.79–1.01; p = 0.022).
Conclusion
Most women with hr-HPV had another STI and/or BV, emphasizing an urgent need for STI and BV screening and intensive scale-up of cervical cancer screening and HPV vaccination programmes. Furthermore, the study highlights the need for more extensive research to confirm and understand the relationship between HPV infection and barrier integrity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
- School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
- School of Nursing and Public Health, Discipline of Public Health Medicine, University of KwaZulu-Natal, Durban, South Africa.
- Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
- Centre for Epidemic Response and Innovation, Stellenbosch University, Cape Town, South Africa.
ORCID-Profile: Andile Mtshali, Lenine Liebenberg
Förderung
- NIAID NIH HHS
- Poliomyelitis Research Foundation
- United States – South African Program for Collaborative Biomedical Research grant
- CAPRISA Research Administration and Management Training Program
- DST-NRF CoE in HIV Prevention
- DST/NRF Innovation Postdoctoral Fellowship
Zitieren
APA
Qulu, W., Mtshali, A., Osman, F., Ndlela, N., Ntuli, L., Mzobe, G., Naicker, N., Garrett, N., Rompalo, A., Mindel, A., Ngcapu, S., & Liebenberg, L. (2023). High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV. PLOS ONE. https://doi.org/10.1371/journal.pone.0294698
Vancouver
Qulu W, Mtshali A, Osman F, Ndlela N, Ntuli L, Mzobe G, et al. High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV. PLOS ONE. 2023. doi:10.1371/journal.pone.0294698
BibTeX
@article{Qulu2023,
author = {Qulu, Wenkosi and Mtshali, Andile and Osman, Farzana and Ndlela, Nonsikelelo and Ntuli, Lungelo and Mzobe, Gugulethu and Naicker, Nivashnee and Garrett, Nigel and Rompalo, Anne and Mindel, Adrian and Ngcapu, Sinaye and Liebenberg, Lenine},
title = {High-risk human papillomavirus prevalence among South African women diagnosed with other STIs and BV},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0294698}
}
EUVIMED